Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
US Army
US Department of Justice
Daiichi Sankyo
Dow
Harvard Business School
Boehringer Ingelheim
Fish and Richardson
Chinese Patent Office

Generated: April 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021199

« Back to Dashboard

NDA 021199 describes QUIXIN, which is a drug marketed by Santen and is included in one NDA. Additional details are available on the QUIXIN profile page.

The generic ingredient in QUIXIN is levofloxacin. There are thirty drug master file entries for this compound. Fifty-nine suppliers are listed for this compound. Additional details are available on the levofloxacin profile page.
Summary for 021199
Tradename:QUIXIN
Applicant:Santen
Ingredient:levofloxacin
Patents:0
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:SOLUTION/DROPS;OPHTHALMICStrength0.5% **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Aug 18, 2000TE:RLD:Yes

Expired US Patents for NDA 021199

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Santen QUIXIN levofloxacin SOLUTION/DROPS;OPHTHALMIC 021199-001 Aug 18, 2000 ➤ Sign Up ➤ Sign Up
Santen QUIXIN levofloxacin SOLUTION/DROPS;OPHTHALMIC 021199-001 Aug 18, 2000 ➤ Sign Up ➤ Sign Up
Santen QUIXIN levofloxacin SOLUTION/DROPS;OPHTHALMIC 021199-001 Aug 18, 2000 ➤ Sign Up ➤ Sign Up
Santen QUIXIN levofloxacin SOLUTION/DROPS;OPHTHALMIC 021199-001 Aug 18, 2000 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Daiichi Sankyo
Chinese Patent Office
Argus Health
Boehringer Ingelheim
Baxter
Queensland Health
Fish and Richardson
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.